Results 181 to 190 of about 32,808 (269)

Correction: Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition. [PDF]

PLoS Biol, 2020
Kettunen J, Holmes MV, Allara E, Anufrieva O, Ohukainen P, Oliver-Williams C, Wang Q, Tillin T, Hughes AD, Kähönen M, Lehtimäki T, Viikari J, Raitakari OT, Salomaa V, Järvelin MR, Perola M, Smith GD, Chaturvedi N, Danesh J, Di Angelantonio E, Butterworth AS, Ala-Korpela M.   +21 more
europepmc   +1 more source

Downregulation of cholesteryl ester transfer protein by glucocorticoids: a randomised study on HDL

European Journal of Clinical Investigation, 2017
Jorien Werumeus Buning, Lidya G Dimova, F. Perton, U. Tietge, A. V. van Beek, R. Dullaart   +5 more
semanticscholar   +1 more source

Discovery of novel cholesteryl ester transfer protein (CETP) inhibitors by a multi-stage virtual screening. [PDF]

BMC Chem
Liu Y, Deng L, Ding F, Wang Q, Zhang S, Mi N, Zhang W, Zeng B, Tong H, Wu L.   +9 more
europepmc   +1 more source

Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

Journal of Clinical Investigation, 1996
Shaobin Zhong, Dan S. Sharp, John S. Grove, C. Bruce, Katsuhiko Yano, J. Curb, Alan R. Tall   +6 more
semanticscholar   +1 more source

Assessing lipid-lowering and plasma cholesteryl ester transfer protein activity of <i>Centranthus longiflorus</i> and β-Sitosterol following administration to triton WR1339- treated rats. [PDF]

Food Sci Nutr
Askin S, Umudum FZ.
europepmc   +1 more source

Present therapeutic role of cholesteryl ester transfer protein inhibitors

Pharmacological Research, 2018
N. Ferri, A. Corsini, C. Sirtori, M. Ruscica   +3 more
semanticscholar   +1 more source

Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non-human primate studies and clinical trials. [PDF]

Pharmacol Res Perspect
Nicholls SJ, Nelson AJ, Kastelein JJP, Ditmarsch M, Hsieh A, Johnson J, Curcio D, Kling D, Kirkpatrick CF, Davidson MH.   +9 more
europepmc   +1 more source

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk.

Diabetes & Metabolism, 2018
W. Masson, M. Lobo, D. Siniawski, M. Huerín, G. Molinero, René Valéro, J. Nogueira   +6 more
semanticscholar   +1 more source

The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.

New England Journal of Medicine, 1998
J. Kuivenhoven, J. Jukema, A. Zwinderman, P. de Knijff, R. McPherson, A. V. Bruschke, K. Lie, J. Kastelein   +7 more
semanticscholar   +1 more source

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein

Arteriosclerosis, Thrombosis and Vascular Biology, 2016
G. Reyes-Soffer, J. Millar, C. Ngai, Patricia A. Jumes, Ellie Coromilas, B. Asztalos, A. Johnson-Levonas, J. Wagner, D. Donovan, W. Karmally, R. Ramakrishnan, S. Holleran, T. Thomas, Richard L. Dunbar, Emil M Degoma, Hashmi Rafeek, A. Baer, Yang Liu, Michael E. Lassman, D. Gutstein, D. Rader, H. Ginsberg   +21 more
semanticscholar   +1 more source